On the stock market since 2011, it operates in the world of money and finance. Now — the numbers.
The company is still in the product-building phase: its spending runs far above its sales. That only changes once the product starts selling at scale.
The stock trades near its peak today. For long-term holders the ride has paid off so far — though past performance guarantees nothing about the future.
Sales run at $21.5M a year. A small number, but proof the product has real buyers.
It pays out $1.22 per share each year — regular cash for whoever holds the stock.
A loss of $75.3M against $21.5M in annual sales.
On our five-subject report card, NFRAX sits behind the class. A low grade doesn’t mean “doomed” — it means “big claim, small proof.”
The takeaway: NFRAX is a high-risk stock — not yet profitable, and its future rides on its product catching on.